Details of the Drug Combinations

General Information of This Drug (ID: DMRBUPA)

Drug Name

Potassium Citrate DMRBUPA

Synonyms

Urocit-k

Indication

Disease Entry	ICD 11	Status	REF
Hypokalemia	5C77	Approved	[1]
Kidney stone	GB70.0Z	Approved	[2]
Renal tubular acidosis	N.A.	Approved	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL is unavailable

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

5 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Clarithromycin + Potassium Citrate	DCPTEJY	Clarithromycin	Helicobacter Pylori	[3]
Potassium Citrate + Torasemide	DCCCS4I	Torasemide	Congenital Mitral Insufficiency	[4]
Potassium Citrate + Torasemide	DCEC9GY	Torasemide	Heart Failure Congenital	[5]
Sodium bicarbonate + Potassium Citrate	DCFPPZ8	Sodium bicarbonate	Kidney Stone	[6]
Esomeprazole + Potassium Citrate	DCBKP42	Esomeprazole	Helicobacter Infections	[7]
------------------------------------------------------------------------------------

References

1	Potassium Citrate FDA Label
2	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
3	ClinicalTrials.gov (NCT02892409) TAK-438 Bismuth Drug Interaction Study
4	ClinicalTrials.gov (NCT06037434) Study of Innovative Drug Treatment Therapy for Pediatric Mitral Regurgitation
5	ClinicalTrials.gov (NCT06039540) Study of Drug Therapy for Pediatric Heart Failure
6	ClinicalTrials.gov (NCT04651088) Comparing Alkalinizing Agents Efficacy on Stone Risk in Patients on a Metabolically Controlled Diet
7	ClinicalTrials.gov (NCT01792700) Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy